Compare ACN & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACN | PFE |
|---|---|---|
| Founded | 1989 | 1849 |
| Country | Ireland | United States |
| Employees | 779000 | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.6B | 145.4B |
| IPO Year | N/A | N/A |
| Metric | ACN | PFE |
|---|---|---|
| Price | $270.53 | $25.23 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 22 | 10 |
| Target Price | ★ $302.05 | $27.40 |
| AVG Volume (30 Days) | 4.6M | ★ 52.7M |
| Earning Date | 12-18-2025 | 02-03-2026 |
| Dividend Yield | 2.40% | ★ 6.83% |
| EPS Growth | 1.33 | ★ 131.89 |
| EPS | ★ 12.09 | 1.73 |
| Revenue | ★ $70,725,557,000.00 | $62,785,000,000.00 |
| Revenue This Year | $6.73 | N/A |
| Revenue Next Year | $5.40 | N/A |
| P/E Ratio | $22.52 | ★ $14.59 |
| Revenue Growth | ★ 6.58 | 3.89 |
| 52 Week Low | $229.40 | $20.92 |
| 52 Week High | $398.35 | $27.69 |
| Indicator | ACN | PFE |
|---|---|---|
| Relative Strength Index (RSI) | 59.14 | 47.56 |
| Support Level | $261.50 | $24.92 |
| Resistance Level | $276.81 | $25.52 |
| Average True Range (ATR) | 7.14 | 0.58 |
| MACD | -0.07 | -0.09 |
| Stochastic Oscillator | 46.71 | 16.76 |
Accenture is a leading IT services firm that provides consulting, system integration, and business process outsourcing to enterprises around the world. Customers of Accenture come from a variety of sectors, including communications, media and technology, financial services, health and public services, consumer products, and resources. Accenture is the world's largest professional services company by headcount with around 800,000 employees in over 120 countries.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.